How does Ondansetron prevent chemotherapy-induced nausea?

How does ondansetron stop chemotherapy nausea?

Ondansetron prevents chemotherapy-induced nausea and vomiting mainly by blocking serotonin (5-HT3) receptors in the gut and brain. Chemotherapy can damage cells in the gastrointestinal tract, which triggers the release of serotonin. That serotonin then activates 5-HT3 receptors on sensory nerves that signal nausea to the central nervous system. By antagonizing (blocking) these 5-HT3 receptors, ondansetron interrupts the nausea signal pathway, reducing nausea and vomiting after chemotherapy.

Why do 5-HT3 receptors matter after chemotherapy?

After chemotherapy, serotonin release from the gut acts as a key trigger for the emetic (vomiting) reflex. The 5-HT3 receptors are located both:
- In the gastrointestinal tract, where they help transmit the signal from the gut to the brain, and
- In the brainstem, where they contribute to coordinating vomiting.

Blocking 5-HT3 receptors reduces both the signal initiation and the vomiting reflex, which is why ondansetron is effective for the nausea and vomiting that chemotherapy causes.

Does ondansetron work for all types of chemotherapy nausea?

Ondansetron is best known for preventing “acute” nausea and vomiting—symptoms that occur within about the first 24 hours after chemotherapy—because the serotonin-driven signaling that follows chemotherapy injury is most prominent early. (Delayed nausea can involve additional pathways beyond 5-HT3 signaling, so it may require other medications depending on the regimen and risk level.)